2013
Role of central arginine vasopressin receptors in the analgesic effect of CDP-choline on acute and neuropathic pain
Bagdas D, Yucel-Ozboluk H, Orhan F, Kanat O, Isbil-Buyukcoskun N, Gurun M. Role of central arginine vasopressin receptors in the analgesic effect of CDP-choline on acute and neuropathic pain. Neuroreport 2013, 24: 941-946. PMID: 24089014, DOI: 10.1097/wnr.0000000000000009.Peer-Reviewed Original ResearchConceptsCentral AVP receptorsAnalgesic effectAVP V1Pain modelAVP receptorsChronic constriction injury-induced neuropathic pain modelCDP-cholineDifferent pain modelsRandall-Selitto testNeuropathic pain modelAVP V2 receptorsV2 receptor antagonistAVP V2 receptor antagonistArginine vasopressin receptorsNeuropathic painNeuropathic modelsPain modulationIntracerebroventricular injectionPain thresholdReceptor antagonistVasopressin levelsV2 receptorsVasopressin receptorsRatsReceptors
2011
The antihyperalgesic effect of cytidine-5′-diphosphate-choline in neuropathic and inflammatory pain models
Bagdas D, Sonat F, Hamurtekin E, Sonal S, Gurun M. The antihyperalgesic effect of cytidine-5′-diphosphate-choline in neuropathic and inflammatory pain models. Behavioural Pharmacology 2011, 22: 589-598. PMID: 21836465, DOI: 10.1097/fbp.0b013e32834a1efb.Peer-Reviewed Original ResearchConceptsNeuropathic pain modelAntihyperalgesic effectPain modelChronic constriction injury-induced neuropathic pain modelNonselective muscarinic receptor antagonist atropineNonselective opioid receptor antagonist naloxoneΓ-aminobutyric acid B receptorsNicotinic ACh receptor antagonistsReceptor antagonist CGP 35348Muscarinic receptor antagonist atropineNicotinic receptor antagonist mecamylamineOpioid receptor antagonist naloxoneCholine uptake inhibitor hemicholinium-3CDP-cholineEffect of intracerebroventricularlyAntagonist CGP 35348Central opioid receptorsInflammatory pain modelACh receptor antagonistNicotinic ACh receptorsCGP 35348Mechanical hyperalgesiaNeuropathic painAntagonist atropineAntagonist naloxone